46 results about "Human specific" patented technology

A method and apparatus for video retrieval and cueing that automatically detects human faces in the video and identifies face-specific video frames so as to allow retrieval and viewing of person-specific video segments. In one embodiment, the method locates human faces in the video, stores the time stamps associated with each face, displays a single image associated with each face, matches each face against a database, computes face locations with respect to a common 3D coordinate system, and provides a means of displaying: 1) information retrieved from the database associated with a selected person or people, 2) path of travel associated with a selected person or people 3) interaction graph of people in video, 4) video segments associated with each person and/or face. The method may also provide the ability to input and store text annotations associated with each person, face, and video segment, and the ability to enroll and remove people from database. The videos of non-human objects may be processed in a similar manner. Because of the rules governing abstracts, this abstract should not be used to construe the claims.

Collecting images of a patron in an entertainment venue is performed by facial recognition of the patron's face within the images, simplifying the storage and distribution of the images for a patron. In order to enhance the reliability of the facial recognition system, information about the patron that is not directly related to most facial recognition systems, including clothes, height, other associated people, use of glasses and jewelry, disposition of facial hair, and more, can be used. Some of the characteristics used can be specific to a particular date or event, and which will not be more generally characteristic of the patron. The facial recognition system can also be used to identify the patron requesting images to be collected. The present invention also relates to the use of facial recognition in sorting and collecting images from an electronically-stored image collection, enabling the easy retrieval of images that are related to a particular person or set of people.

There is provided a method that includes (a) receiving first information about a patient via a first user interface that is communicatively coupled to a communication network, (b) receiving second information about the patient via a second user interface that is communicatively coupled to the communication network, where the first information and the second information, together, comprise answered questions, (c) evaluating the answered questions, to yield a suggested diagnosis and a follow-up question, and (d) transmitting the suggested diagnosis and the follow-up question to the second user interface via the communication network. There is also provided a system that employs the method, and a storage device that contains instructions that cause a processor to perform the method.

Systems and methods are provided for validating the authenticity of a signature on a document by providing a document from an account, the document including an actual signature and a machine-readable identifier, wherein the machine-readable identifier contains a string of data representing the integral characteristics of all valid account signatures and a person-specific confidence threshold. When the document is presented at a point of presentment, the document is scanned into a document-processing machine and the actual signature is compared against all valid account signatures.

Disclosed is a method for managing obesity, diabetes, hair loss, aging, cardiovascular, or other blood glucose-spike-induced diseases by reducing the post-prandial blood glucose spike, or the glucose shock. The blood glucose spike, or the glucose shock is reduced by generating a person-specific glucose profile for at least one significant meal to tune or train a blood glucose model (kinetic, artificial intelligence or hybrid), and then using the tuned or the trained model embedded in a computation-capable electronic device to compute and recommend a person-specific meal plan and an exercise plan, including semi-continuous meal ingestion and post-meal exercise while sitting at home or office. Advantages over prior art are that the method uses less strenuous exercise with no or less medicine, is person-specific, quantitative and more suitable for use by an individual, a dietician, or a health care practitioner.

It is an object of the present invention to provide a transgenic non-human animal, which can appropriately evaluate properties, pharmacological effects and safety of a molecular targeted substance or targeted drug to a human specific molecule, and to provide a method for producing the transgenic non-human animal, which comprises a gene encoding a human specific molecule and a gene encoding a human Fcγ receptor family, both genes being introduced in the animal, thereby expressing the gene encoding a human specific molecule and the gene encoding a human Fcγ receptor family.

The invention discloses a test paper strip for detecting the concentration of thyroglobulin and a preparation method thereof. The test paper strip comprises strip-shaped nitrocellulose membranes arranged transversely and horizontally, and longitudinally spaced and parallel to each other on the cellulose acetate membrane. A strip-shaped detection line and a quality control line are respectively provided, wherein the end of the nitrocellulose membrane close to the quality control line is abutted against a horizontally arranged strip-shaped water-absorbing pad, and the end of the nitrocellulose membrane close to the detection line Butt against a horizontal strip-shaped colloidal gold pad, and the end of the colloidal gold pad away from the nitrocellulose membrane abuts against a horizontally horizontal strip-shaped sample pad; the colloidal gold pad contains a colloidal gold label pair anti-human thyroglobulin antibody, the detection line is coated with a detection antibody that can specifically bind to the anti-human thyroglobulin antibody, and the quality control line is coated with a detection antibody that can specifically bind to the free anti-human thyroglobulin antibody Quality control antibodies.

The present invention includes a plurality of layered materials used to facilitate the removal of sweat and toxins which a person may experience during a physical workout. It is useful for sanitarily wicking away sweat and various other functions which may be specific to a person's needs such as carrying important items.

The invention relates to the antibody engineering medicine and particularly relates to the phage antibody display technology, namely a construction method of a human agkistrodon acutus venom immune ScFv antibody library. The method comprises the following steps of: performing PCR (polymerase chain reaction) amplification by use of human specific IgG light chain and heavy chain primers to obtain PCR products; mixing all PCR products to obtain a light chain PCR mixed product and a heavy chain PCR mixed product respectively; introducing specific primers by taking the light chain PCR mixed product and heavy chain PCR mixed product as templates, and performing PCR amplification to obtain a Linker-VL fragment and a VH-Linker fragment; connecting the obtained Linker-VL fragment and the obtained VH-Linker fragment to obtain a VH-Linker-VL fragment; and importing the obtained VH-Linker-VL fragment into a phage cloning vector to obtain an original library of the human agkistrodon acutus venom immune ScFv antibody library.

The invention provides a human cell specific gene fragment, a specific primer and a probe thereof, and a method for specific quantitative detection of a human gene. According to the invention, throughthe NCBI website and a BLAST sequence comparison function of the NCBI website, a human specific gene fragment with a length of 166 bp on FOXP2 gene is obtained, and human genes in tissues, blood andother non-human samples of various preclinical animals are quantified by qPCR. The human cell specific gene fragment and qPCR quantitative detection method adopted by the invention are high in specificity, strong in sensitivity, good in repeatability and simpler and more convenient to operate, and provide a new thought and a corresponding technical support for quantitative detection of specific human genes.

The invention discloses a specific human gene fragment, a primer and a probe for detecting the specific human gene fragment and application of the specific human gene fragment, and particularly discloses a method comprising the following steps: screening the human specific gene fragment, designing, synthesizing and verifying the specific primer probe, constructing a standard plasma and acquiring the accurate relative molecular mass, drawing a standard curve and finally conducting qPCR (Polymerase Chain Reaction) quantitative detection. Therefore, the most important characteristic of the specific human gene fragment lies in that due to the quite strong specificity of the probe and the primer, a human cell in a sample mixed with other animal sources can be qualitatively and quantitatively detected; a carrier T5 is also known for the first time to be used in the construction of the standard plasma, the time is saved, and the cost is also lowered; and the various steps of a method are optimized, so that the detection is more accurate and sensitive.

Human biliary tree stem/progenitors (hBTSCs) are being used for cell therapies of patients with liver cirrhosis. A cryopreservation method was established to optimize sourcing of hBTSCs for these clinical programs and that comprises serum-free Kubota's Medium (KM) supplemented with 10% dimethyl sulfoxide (DMSO), ˜3% recombinant human albumin and 0.1% hyaluronans. Cryopreserved versus freshly isolated hBTSCs were similar in vitro with respect to self-replication, stemness traits, and multipotency. They were able to differentiate to functional hepatocytes, cholangiocytes or pancreatic islets, yielding similar levels of secretion of albumin or of glucose-inducible levels of insulin. Cryopreserved versus freshly isolated hBTSCs were equally able to engraft into immunocompromised mice yielding cells with human-specific gene expression and human albumin levels in murine serum that were higher for cryopreserved than for freshly isolated hBTSCs. The successful cryoypreservation of hBTSCs facilitates establishment of hBTSCs cell banking offering logistical advantages for clinical programs for treatment of liver disease.

The invention pertains to the field of genetic engineering antibody techniques, in particular to a whole human polypeptide single-chain antibody which has specific affinity for human interleukin 21 designed and expressed by genetic engineering. The engineering antibody polypeptide is formed by joining the light chain and heavy chain variable regions of the antibody end to end with a flexible connecting peptide, wherein, both the framework and complementary determining region of the light chain and heavy chain variable regions are from human. The invention screens out the antibody having specific affinity for human interleukin 21 by a cycle operation of 'gathering-elusion-gathering', and then obtains human specific binding human interleukin 21 through a secretary expression system and an affinity purification system. The antibody of the invention can be applied to coupling to detectable substances and therapeutic agents.